We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+13.69%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.1B
AUM Growth
+$6.76B
(+15%)
Cap. Flow
+$2.33B
Cap. Flow
% of AUM
4.39%
Top 10 Holdings %
Top 10 Hldgs %
14.65%
Holding
2,220
New
169
Increased
729
Reduced
1,033
Closed
165
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zscaler
ZS
|
+$222M |
| 2 |
Palantir
PLTR
|
+$221M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$213M |
| 4 |
FirstEnergy
FE
|
+$189M |
| 5 |
Broadcom
AVGO
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$383M |
| 2 |
Philip Morris
PM
|
+$280M |
| 3 |
Entergy
ETR
|
+$207M |
| 4 |
Paychex
PAYX
|
+$206M |
| 5 |
Gilead Sciences
GILD
|
+$201M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.81% |
| 2 | Healthcare | 14.57% |
| 3 | Financials | 13.43% |
| 4 | Industrials | 10.29% |
| 5 | Consumer Discretionary | 9.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
MP Materials
MP
$9.97B
| $1.91M | ﹤0.01% |
57,549
-28,618
| -33% | -$730K |
|
|
BA.PRA
952
Boeing Co 6.00% Series A Preferred Stock
BA.PRA
$7.43B
| – | – |
0
| – | – |
|
953
Patria Investments
PAX
$1.84B
| $1.9M | ﹤0.01% |
135,000
| – | – |
|
954
Bunge Global
BG
$21.6B
| $1.9M | ﹤0.01% |
23,620
-14,178
| -38% | -$1.12M |
|
955
Steven Madden
SHOO
$3.27B
| $1.89M | ﹤0.01% |
78,802
-454,312
| -85% | -$10.7M |
|
956
Compass Diversified
CODI
$861M
| $1.88M | ﹤0.01% |
+299,774
| New | +$3.34M |
|
957
Zegna
ZGN
$3.69B
| $1.88M | ﹤0.01% |
220,000
+80,000
| +57% | +$645K |
|
958
Oil States International
OIS
$517M
| $1.86M | ﹤0.01% |
346,435
+7,690
| +2% | +$34K |
|
959
Keysight
KEYS
$54.6B
| $1.85M | ﹤0.01% |
11,307
+890
| +9% | +$136K |
|
960
COPT Defense Properties
CDP
$4.2B
| $1.85M | ﹤0.01% |
66,936
+49,704
| +288% | +$1.35M |
|
961
LifeMD
LFMD
$154M
| $1.84M | ﹤0.01% |
+135,198
| New | +$1.28M |
|
962
Infosys
INFY
$49.2B
| $1.83M | ﹤0.01% |
98,902
+2,370
| +2% | +$42.3K |
|
963
Magnolia Oil & Gas
MGY
$6.23B
| $1.83M | ﹤0.01% |
81,508
-38,726
| -32% | -$858K |
|
964
Ashland
ASH
$3.36B
| $1.83M | ﹤0.01% |
36,438
+17,870
| +96% | +$909K |
|
965
Graco
GGG
$12.7B
| $1.83M | ﹤0.01% |
21,289
+852
| +4% | +$70.6K |
|
|
966
Bristol-Myers Squibb
BMY
$136B
| $1.83M | ﹤0.01% |
39,478
-7,793,300
| -99% | -$383M |
|
|
WBS
967
DELISTED
Webster Financial
WBS
| $1.82M | ﹤0.01% |
33,360
+14,226
| +74% | +$709K |
|
968
Principal Financial Group
PFG
$24B
| $1.81M | ﹤0.01% |
22,767
-1,139
| -5% | -$87.4K |
|
969
Emergent Biosolutions
EBS
$307M
| $1.78M | ﹤0.01% |
279,469
+328
| +0.1% | +$1.88K |
|
970
Hanover Insurance
THG
$7.94B
| $1.78M | ﹤0.01% |
10,481
-2,761
| -21% | -$461K |
|
971
Financial Institutions
FISI
$807M
| $1.78M | ﹤0.01% |
69,125
-149
| -0.2% | -$3.72K |
|
|
ACLX
972
DELISTED
Arcellx
ACLX
| $1.77M | ﹤0.01% |
26,935
-19,289
| -42% | -$1.2M |
|
973
Casey's General Stores
CASY
$27.9B
| $1.77M | ﹤0.01% |
3,465
-50
| -1% | -$23K |
|
974
Bread Financial
BFH
$4.1B
| $1.76M | ﹤0.01% |
30,818
-264
| -0.8% | -$13.3K |
|
975
Southwest Gas
SWX
$6.48B
| $1.76M | ﹤0.01% |
23,656
-6,509
| -22% | -$469K |
|
Similar funds
Federated Hermes's Q2 2025 Portfolio in Review
As of Q2 2025, Federated Hermes held 2,220 positions worth $53.1B, up 15% from $46.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes deployed $2.33B of net new capital in Q2 2025, opening 169 new positions and adding to 729 existing holdings. Its largest new stake was Genuine Parts: 882,160 shares worth $107M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $383M trimmed.
- Federated Hermes's largest Q2 2025 buy was Genuine Parts: 882,160 shares worth $107M.
- Federated Hermes added most to Zscaler in Q2 2025, an estimated $222M increase.
- Federated Hermes's biggest Q2 2025 reduction was Bristol-Myers Squibb, cutting an estimated $383M.
- Federated Hermes fully exited Regulus Therapeutics in Q2 2025, selling an estimated $39.2M.
- Federated Hermes's ten largest holdings make up 15% of its $53.1B portfolio in Q2 2025.
- Federated Hermes opened 169 new positions and closed 165 in Q2 2025.
- Federated Hermes's portfolio value rose 15% quarter-over-quarter to $53.1B.
Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.